Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Moderna Up After Fauci Says Phase 3 Trial On Schedule for July

Published 07/09/2020, 12:33 PM
Updated 07/09/2020, 01:07 PM
© Reuters.

By Christiana Sciaudone

Investing.com -- Moderna (NASDAQ:MRNA) Inc. is up 2.6% after dropping 5% following a report that its Covid-19 vaccine will likely be going into advanced phase three clinical trials by the end of this month, Reuters reported.

The phase 3 clinical trial had reportedly been delayed because Moderna was changing the protocol of the research, The Motley Fool reported.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Thursday he hopes that there will be a vaccine ready by the end of 2020 or early 2021.

Shares have more than tripled in 2020.

Moderna is among five companies developing coronavirus vaccines that will testify before a sub-committee of the U.S. House Of Representatives later this month, Reuters reported.

Latest comments

Moderna will win this race.
Am i the only one who Is mad that we Aren't getting any Answers? Please Hurry up and find us one.
Forget herd immunity, the same people can and have contracted the virus multiple times
herd immunity will be high enough before an effective vaccine is even found. recent study shows that hydroxychloroquine can reduce deaths by up to 50% and that drug is basically free. these vaccines they are wanting around $2000/dose and are barely effective. COVID-1984 is such as scam. current death rate is below that of the common flu.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.